129 related articles for article (PubMed ID: 6380499)
1. Conformational aspects of angiotensinogen analogues with renin inhibitory activity.
Liepina I; Nikiforovich GV; Paiva AC
Biochem Biophys Res Commun; 1984 Jul; 122(2):700-5. PubMed ID: 6380499
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of renin by conformationally restricted analogues of angiotensinogen.
Nakaie CR; Oliveira MC; Juliano L; Paiva AC
Biochem J; 1982 Jul; 205(1):43-7. PubMed ID: 6751323
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of renin by angiotensinogen peptide fragments containing the hydroxy amino acid residue 5-amino-3-hydroxy-7-methyloctanoic acid.
Johnson RL; Verschoor K
J Med Chem; 1983 Oct; 26(10):1457-62. PubMed ID: 6352942
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of renin by human des-angiotensin I renin substrate.
Barrett JD; Eggena P; Hidaka H; Sambhi MP
J Clin Endocrinol Metab; 1979 Jan; 48(1):96-100. PubMed ID: 422710
[TBL] [Abstract][Full Text] [Related]
5. Lack of inhibition of human renin by human des-angiotensin I renin substrate.
Hiwada K; Sogo Y; Takada Y; Kokubu T
Biochem Pharmacol; 1981 Sep; 30(18):2630-1. PubMed ID: 7030349
[No Abstract] [Full Text] [Related]
6. Conformations of synthetic tetradecapeptide renin substrate and of angiotensin I in aqueous solution.
Oliveira MC; Juliano L; Paiva AC
Biochemistry; 1977 Jun; 16(12):2606-11. PubMed ID: 19034
[TBL] [Abstract][Full Text] [Related]
7. Peptide analogues of angiotensinogen. Effect of peptide chain length on renin inhibition.
Plattner JJ; Greer J; Fung AK; Stein H; Kleinert HD; Sham HL; Smital JR; Perun TJ
Biochem Biophys Res Commun; 1986 Sep; 139(3):982-90. PubMed ID: 3533075
[TBL] [Abstract][Full Text] [Related]
8. Computer simulation of the conformational behaviour of angiotensinogen (6-13) renin substrate.
Benkoulouche M; Cotrait M; Maigret B
J Comput Aided Mol Des; 1992 Feb; 6(1):79-91. PubMed ID: 1583541
[TBL] [Abstract][Full Text] [Related]
9. Exploiting the molecular template of angiotensinogen in the discovery and design of peptidyl, pseudopeptidyl and peptidimimetic inhibitors of human renin: a structure-activity perspective.
Sawyer TK; Hester JB; Schostarez HJ; Thaisrivongs S; Bundy GL; Liu L; Bradford VS; De Vaux AE; Staples DJ; Maggiora LL
Adv Exp Med Biol; 1991; 306():307-23. PubMed ID: 1812721
[No Abstract] [Full Text] [Related]
10. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
TenBrink RE; Pals DT; Harris DW; Johnson GA
J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of renin: present and future.
Haber E
Clin Exp Hypertens A; 1983; 5(7-8):1193-205. PubMed ID: 6357563
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of human renin inhibitory peptides, angiotensinogen transition-state analogs containing a retro-inverso amide bond.
Harada H; Iizuka K; Kamijo T; Akahane K; Yamamoto R; Nakano Y; Tsubaki A; Kubota T; Shimaoka I; Umeyama H
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3042-7. PubMed ID: 2085885
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human renin by rat plasma. Rat angiotensinogen is a competitive inhibitor of the human renin-substrate interaction.
Gahnem F; Sealey JE; Atlas SA; Laragh JH
Am J Hypertens; 1992 Aug; 5(8):495-501. PubMed ID: 1388958
[TBL] [Abstract][Full Text] [Related]
14. Comparison of angiotensinogen and tetradecapeptide as substrates for human renin. Substrate dependence of the mode of inhibition of renin by a statine-containing hexapeptide.
Stammers DK; Dann JG; Harris CJ; Smith DR
Arch Biochem Biophys; 1987 Nov; 258(2):413-20. PubMed ID: 3314712
[TBL] [Abstract][Full Text] [Related]
15. Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogues of angiotensinogen.
Sham HL; Bolis G; Stein HH; Fesik SW; Marcotte PA; Plattner JJ; Rempel CA; Greer J
J Med Chem; 1988 Feb; 31(2):284-95. PubMed ID: 3276890
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of renin and their utility in physiologic studies.
Haber E; Burton J
Fed Proc; 1979 Dec; 38(13):2768-73. PubMed ID: 510563
[TBL] [Abstract][Full Text] [Related]
17. Conformationally constrained renin inhibitory peptides: cyclic (3-1)-1-(carboxymethyl)-L-prolyl-L-phenylalanyl-L-histidinamide as a conformational restriction at the P2-P4 tripeptide portion of the angiotensinogen template.
Thaisrivongs S; Blinn JR; Pals DT; Turner SR
J Med Chem; 1991 Apr; 34(4):1276-82. PubMed ID: 2016704
[TBL] [Abstract][Full Text] [Related]
18. The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin.
Nakagawa T; Akaki J; Satou R; Takaya M; Iwata H; Katsurada A; Nishiuchi K; Ohmura Y; Suzuki F; Nakamura Y
Biol Chem; 2007 Feb; 388(2):237-46. PubMed ID: 17261087
[TBL] [Abstract][Full Text] [Related]
19. New renin inhibitors containing novel analogues of statine.
Jones DM; Sueiras-Diaz J; Szelke M; Leckie BJ; Beattie SR; Morton J; Neidle S; Kuroda R
J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895
[TBL] [Abstract][Full Text] [Related]
20. Structure-conformation relationships of synthetic peptide inhibitors of human renin studied by resonance energy transfer and molecular modeling.
Epps DE; Mao B; Staples DJ; Sawyer TK
Int J Pept Protein Res; 1988 Jan; 31(1):22-34. PubMed ID: 3284834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
